While extensive research has elucidated the mechanisms underlying the RB family, particularly the role of its gene product, pRB, clinical and mechanistic studies examining the impact of RB1 on the prognosis of MM remain limited. This evidence concerns the gene RB1 and Miyoshi myopathy.